Gland Pharma
Latest news, explainers and analysis on Gland Pharma. Tracking 3 stories on Arth Vani.
Connected in the graph
Latest on Gland Pharma
Gland Pharma Q1 Profit Surges 47% to ₹317 Crore on Strong US and Europe Sales
Gland Pharma reported a 47% year-on-year jump in net profit to ₹317 crore for the first quarter of FY25, driven by a 20% rise in revenue. The growth was fueled by strong performance in the CDMO and B2B segments across the US and European markets.
Gland Pharma Bags Mega CDMO Deal; Targets ₹840 Crore Annual Revenue
Hyderabad-based Gland Pharma has signed a major manufacturing agreement with a global pharmaceutical giant to produce 55 sterile injectable products. The deal is expected to generate annual revenues of $90-100 million (approx. ₹750-840 crore) starting from 2029.
Gland Pharma Gets US FDA Nod for Generic Sugammadex Injection
Gland Pharma has received US FDA approval for its generic version of sugammadex injection, a drug used to reverse muscle relaxants during surgery. This approval marks a significant step for the company in the US market.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.